Clinical data
ATC code None
CAS Number 105051-87-4
PubChem (CID) 65886
ChemSpider 59295
Chemical and physical data
Formula C19H23NO2
Molar mass 297.391 g/mol
3D model (Jmol) Interactive image

Minamestane (INN (former developmental code name FCE-24,928) is a steroidal aromatase inhibitor which was under development by Farmitalia-Carlo Erba as an antineoplastic agent in the mid-1990s but was never marketed.[1][2][3]

Unlike other steroidal aromatase inhibitors such as formestane and exemestane, minamestane does not have androgenic properties.[2]

See also


  1. F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1357. ISBN 978-0-412-46630-4. Retrieved 20 May 2012.
  2. 1 2 Di Salle E, Briatico G, Giudici D, et al. (June 1994). "Novel aromatase and 5 alpha-reductase inhibitors". The Journal of Steroid Biochemistry and Molecular Biology. 49 (4-6): 289–94. doi:10.1016/0960-0760(94)90270-4. PMID 8043491.
  3. Combs, Donald W (1995). "Review Oncologic, Endocrine & Metabolic: Recent developments in aromatase inhibitors". Expert Opinion on Therapeutic Patents. 5 (6): 529533. doi:10.1517/13543776.5.6.529. ISSN 1354-3776.

This article is issued from Wikipedia - version of the 12/4/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.